Skip to main content
An official website of the United States government
The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Search:
Agenda
Reg Review
ICR
This script is used to control the display of information in this page.
Display additional information by clicking on the following:
All
Brief and OIRA conclusion
Abstract/Justification
Legal Statutes
Rulemaking
FR Notices/Comments
IC List
Burden
Misc.
Common Form Info.
Certification
View Information Collection (IC) List
View Supporting Statement and Other Documents
Please note that the OMB number and expiration date may not have been determined when this Information Collection Request and associated Information Collection forms were submitted to OMB. The approved OMB number and expiration date may be found by clicking on the Notice of Action link below.
View ICR - OIRA Conclusion
OMB Control No:
0920-0199
ICR Reference No:
202004-0920-018
Status:
Historical Active
Previous ICR Reference No:
201803-0920-004
Agency/Subagency:
HHS/CDC
Agency Tracking No:
0920-0199-20NJ
Title:
Import Permit Applications (42 CFR 71.54)
Type of Information Collection:
No material or nonsubstantive change to a currently approved collection
Common Form ICR:
No
Type of Review Request:
Regular
OIRA Conclusion Action:
Approved with change
Conclusion Date:
04/29/2020
Retrieve Notice of Action (NOA)
Date Received in OIRA:
04/27/2020
Terms of Clearance:
Inventory as of this Action
Requested
Previously Approved
Expiration Date
04/30/2021
04/30/2021
04/30/2021
Responses
4,500
0
4,400
Time Burden (Hours)
1,355
0
1,322
Cost Burden (Dollars)
0
0
0
Abstract:
CDC requests Office of Management and Budget approval to collect information for three years. CDC revised the Application for Permit to Import Biological Agents, Infectious Substances and Vectors of Human Disease into the U.S. to remove questions that are duplicative or not required to process the import permit request and added questions requesting biosafety officer's contact information and verifying biosafety measures for any subsequent transfers listed on the import permit application of infectious biological agent infectious substance, and/or vector once in the U.S. CDC revised the Application for Permit to Import or Transport Live Bats to add a question about what protective measures will be used. This Change Request is associated with the COVID-19 Emergency Response. We are adding an additional form (Application Permit For Importation of Human Remains) that will be used by facilities that will bury/cremate the imported cadaver and educational facilities to request a permit for the importation and subsequent transfers throughout the U.S. of human remains or body parts that contains biological agents, infectious substances, or vectors of human disease. The CDC/IPP will review the application for permits to ensure that the imported human remains have appropriate biosafety measures in place to protect the public from exposure to blood and other body fluids during transportation, inspection, and/or storage of human remains that may be infected with SARS-CoV-2.
Authorizing Statute(s):
US Code:
42 USC 264
Name of Law: PHSA
US Code:
42 USC CFR Part 71.54
Name of Law: FOREIGN QUARANTINE - Subpart F--Importations
Citations for New Statutory Requirements:
None
Associated Rulemaking Information
RIN:
Stage of Rulemaking:
Federal Register Citation:
Date:
Not associated with rulemaking
Federal Register Notices & Comments
60-day Notice:
Federal Register Citation:
Citation Date:
82 FR 44795
09/26/2017
30-day Notice:
Federal Register Citation:
Citation Date:
83 FR 10484
03/09/2018
Did the Agency receive public comments on this ICR?
No
Number of Information Collection (IC) in this ICR:
6
IC Title
Form No.
Form Name
Application for Permit to Import Infectious Biological Agents into the United States
0920-0199
Application for Permit to Import Infectious Biological Agents into the United States
Application for Permit to Import or Transport Live Bats (71.54)
0920-0199
Application for Permit to Import or Transfer Live Bats
Guidance Document for Completing Application for Permit to Import or Transport Live Bats (71.54)
0920-0199
Guidance for Completing the Application for Permit to Import or Transfer Live Bats
Guidance Document for Completing the Application for Permit to Import Biological Agents into the United States
0920-0199
Application for Permit to Import Infectious Biological Agents into the United States
Permit to Import Human Remains
0920-0199
Permit to Import Human Remains
Susequent Transfer - Application for Permit to Import Infectious Biological Agents into the United States
0920-0199
Sebsequent Transfer - Application for Permit to Import Infectious Biological Agents into the United States
ICR Summary of Burden
Total Approved
Previously Approved
Change Due to New Statute
Change Due to Agency Discretion
Change Due to Adjustment in Estimate
Change Due to Potential Violation of the PRA
Annual Number of Responses
4,500
4,400
0
100
0
0
Annual Time Burden (Hours)
1,355
1,322
0
33
0
0
Annual Cost Burden (Dollars)
0
0
0
0
0
0
Burden increases because of Program Change due to Agency Discretion:
Yes
Burden Increase Due to:
Miscellaneous Actions
Burden decreases because of Program Change due to Agency Discretion:
No
Burden Reduction Due to:
Short Statement:
A form was added to the collection but this Change Request falls under Emergency review because it is related to COVID-19.
Annual Cost to Federal Government:
$1,335,495
Does this IC contain surveys, censuses, or employ statistical methods?
Yes
Part B of Supporting Statement
Does this ICR request any personally identifiable information (see
OMB Circular No. A-130
for an explanation of this term)? Please consult with your agency's privacy program when making this determination.
No
Does this ICR include a form that requires a Privacy Act Statement (see
5 U.S.C. §552a(e)(3)
)? Please consult with your agency's privacy program when making this determination.
No
Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]?
No
Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]?
No
Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)?
No
Is this ICR related to the Pandemic Response?
Yes
Agency Contact:
Kevin Joyce 404 639-1944 kdj7@cdc.gov
Common Form ICR:
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(a) It is necessary for the proper performance of agency functions;
(b) It avoids unnecessary duplication;
(c) It reduces burden on small entities;
(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;
(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;
(f) It indicates the retention periods for recordkeeping requirements;
(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.
(i) It uses effective and efficient statistical survey methodology (if applicable); and
(j) It makes appropriate use of information technology.
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Certification Date:
04/27/2020